Chinese Biotechs Refuel AI Enthusiasm After DeepSeek Breakout

 
• By Dexter Jie Yan

In one sign of renewed interest in AI tools from Chinese biotechs, Harbour BioMed has linked with InSilico Medicine for antibody discovery. Meanwhile, Antengene and AIM Vaccine will use DeepSeek's AI technology to support drug and vaccine development.

More Chinese biotechs look to artificial intelligence after the DeepSeek hit. (Shutterstock)

More from R&D

More from Business